[Plasticity of adult stem cells].

By A. Turhan. Transfusion Clinique et Biologique, 2003

1,288 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/f90b847595bf9a96913c8a0f8a90c249b20aa98a

Citations in the corpus

• Beyond tumorigenesis: cancer stem cells in metastasis (2007, unknown): “Although no direct experimental evidence is currently available for the cell fusion origin of CSCs, as mentioned above, cell fusion has been shown to be one of the mechanisms for the apparent cellular plasticity associated with tissue stem cells [ 8 ].”
• Adult mesenchymal stem cells for tissue engineering versus regenerative medicine (2007, unknown): “To maintain red blood cell numbers, the red blood cell (rbc) progenitors must be proceeding toward maturation, so that, as an existing rbc expires, its replacement has just reached maturity (Owen, 1985; Wagers and Weissman, 2004).”
• Systems biology of stem cell fate and cellular reprogramming (2009, unknown): “Embryonic stem (ES) cells — which are derived from the inner cell mass of the developing blastocyst — are pluripotent, whereas stem cells derived from adult tissues are generally only multipotent, maintaining a limited, tissue-specific, regenerative potentia”
• Mesenchymal stem cells reside in virtually all post-natal organs and tissues (2006, unknown): “Experiments using bone marrow cells have raised the issue of phenotypic plasticity (Herzog et al., 2003; Wagers and Weissman, 2004), because they have shown the consequent generation of specialized cells derived from bone marrow in the central nervous system (Eglitis and Mezey, 1997; Mezey et al.,…”
• Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. (2004, unknown): “Finally, when sues, including epidermis, intestine, muscle, the hema- marked rodent bulge cells are transplanted onto athymic topoetic system, and even brain (Weissman et al., 2001; mice, their progeny can be detected in the resulting Wagers and Weissman, 2004 ).”
• Bone marrow-derived mesenchymal stem cells in repair of the injured lung. (2005, unknown): “It is possible that the donor cell phenotype in these studies included stem cells that fused with resident cells, as has been suggested in other studies (16), rather than differentiation (17).”
• Somatic cell reprogramming and transitions between pluripotent states: facts, hypotheses, unresolved issues (2010, unknown): “…molecular definition of different pluripotent states and strategies to convert one cell state into another; (2) molecular concepts of somatic cell reprog- 508 Cell 143, November 12, 2010 ª2010 Elsevier Inc. ramming to pluripotency; and (3) direct transdifferentiation between somatic cell states.”
• Embryonic stem cells: prospects for developmental biology and cell therapy. (2005, unknown): “While the differentiation potential of some adult stem cells (hematopoietic and mesenchymal) are wellcharacterized in vivo (HSC) or in vitro (MSC), the transdifferentiation potential of most adult stem cells remains controversial (235, 378, 379), partly as a consequence of culture conditions (175), ”
• Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. (2005, unknown): “Despite the recent negative reports about transdifferentiation (3, 16, 36), clinical trials with bone marrow-derived cell populations have been published and in part proven effective in the treatment of myocardial infarction (31, 33, 39).”
• Mechanisms of mesenchymal stem/stromal cell function (2016, unknown): “to tissues derived from their germ layer of origin [18–20].”